Early research (Phase 1)UnknownNCT04932187
What this trial is testing
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)
Who this might be right for
Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)
Ruijin Hospital 20